Alex Lipnik | The Pre Roll

Alex Lipnik

🌿 Senate funding bill includes hemp ban delay, FAA reviews cannabis rules for aviation personnel, and Thailand moves toward medical cannabis only limits

Welcome to another edition of The Pre Roll, the cannabis newsletter that keeps you up-to-date on the industry happenings you need to know. Here’s what we’re rolling up this week: Senate funding bill includes hemp ban delay, FAA reviews cannabis rules for aviation personnel, Thailand moves toward medical cannabis only limits, and more. Let’s get to it.

🌿 Senate funding bill includes hemp ban delay, FAA reviews cannabis rules for aviation personnel, and Thailand moves toward medical cannabis only limits

🌿 Vireo Growth acquires Planet 13, Senators seek cannabis insurance protections, and researchers examine CBD sleep benefits

🌿 Bipartisan hemp reform introduced, Vireo expands cannabis footprint, and Lollapalooza adds THC beverages

🌿 Senators seek real reform, TIME recognizes major MSOs, and rescheduling hearings reach conclusion

🌿 American Bankers Association backs SAFE Banking, Wyoming rejects rescheduling shift, and Missouri workers gain union momentum

🌿 DEA and FDA review cannabis rescheduling risks, bipartisan lawmakers reintroduce SAFE Banking Act, and EDUCATE Act proposed for cannabis education funding

🌿 DEA rescheduling hearing draws criticism, U.S. cannabis industry workforce shrinks, and restaurant association opposes THC ban

🌿 Supreme Court curbs cannabis gun ban, Virginia ventures toward adult-use market, and Dutchie debuts new consumer AI tools

🌿 White House urges hemp revision, Trulieve makes historic NYSE debut, and WNBA formalizes new cannabis rules

🌿 Robinhood embraces U.S. cannabis stocks, rescheduling faces mounting legal threat, and Japan enacts nationwide CBN ban

🌿 Democratic lawmakers push for federal cannabis clemency, NORML seeks seat during DEA rescheduling talks, and New York proposes track-and-trace relief

🌿 Virginia adult-use market faces another setback, TSA says airport cannabis policy remains unchanged, and cannabis companies report mixed Q1 2026 results

🌿 Target broadens hemp THC beverage rollout, DEA extends medical cannabis registration system, and U.S. cannabis licensing continues years long decline

🌿 MSOs face deceptive marketing lawsuit, FLUENT completes strategic transactions, and cannabis opponents challenge federal rescheduling

🌿 DEA opens dispensary registration portal, Farm Bill advances in House, and Safe Harbor unveils 401(k) plan

🌿 Rescheduling begins with medical focus, Aurora and Tilray widen global reach, and POSaBIT platform expands into supply side

🌿 Edibles.com expands into retail, Army officer disputes cannabis discipline, and IRS clarifies tips remain taxable

🌿 Weedmaps delists from Nasdaq, Vireo Growth advances acquisition strategy, and Whitney Economics highlights 280E tax burden

🌿 Medicare makes way for hemp‐derived products, Vireo secures select assets from Schwazze, and Nebraska hits historic medical cannabis milestone

🌿 The Cannabist Company initiates multi-state exit plan, Army adjusts policy for cannabis convictions, and PharmaCann shuts down production plants

🌿 Virginia nears regulated recreational retail market, bipartisan bill seeks broader access to exchanges, and Kiva Sales & Service and Petalfast plan merger

🌿 Aurora Cannabis moves to medical-only, Alabama looks toward launch, and additional companies announce 2025 results

🌿 Farm Bill moves forward with hemp ban intact, Tilray Brand acquires BrewDog assets, and cannabis companies report 2025 results

🌿 NCIA names new board members, New York targets THC beverages in liquor stores, and Sunderstorm scales KANHA products globally

🌿 Organigram outlines European expansion plan, Virginia vets recreational regulatory frameworks, and iAnthus initiates Arizona asset sale